Search results
As Ozzy Osbourne announces stem cell therapy, experts urge caution, highlight risks
Fox News· 7 days ago"The thing is, you have it, and you go, ‘I don't feel that great,’ but I don't know what it would be...
Is Permanent Eyeliner Worth It? Here's Everything You Need to Know
Real Simple via AOL· 9 hours ago“This doesn't mean that the eyeliner has completely faded away,” Azimi says. “It may partially stay...
Earnings call: Anavex Life Sciences eyes Alzheimer's, Rett syndrome trials By Investing.com
Investing.com· 6 days agoAnavex Life Sciences Corp. (NASDAQ:AVXL) held its fiscal 2024 second-quarter earnings call,...
AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
Zacks via Yahoo Finance· 1 day agoThe acquisition will strengthen AbbVie’s neuroscience pipeline by adding CERE’s novel candidates...
Eisai projects Leqembi® revenue to total JPY 56.5 billion for fiscal year 2024 (April 2024 - March...
WKBN 27 Youngstown· 24 hours agoBioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai today said that they expect Leqembi sales to total JPY 56.5 billion (approximately SEK 4 billion) for their ...
Alice Munro, Nobel Prize-Winning Writer, Dies at 92
People via Yahoo News· 1 day agoNever miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to...
Vaxxinity leaders detail retreat from 'abusive relationship' after 3 years on public market
FierceBiotech· 14 hours agoVaxxinity, which filed to delist from the Nasdaq last month, is choosing radical transparency about...
Jones Trading cuts Anavex target to $15, maintains buy By Investing.com
Investing.com· 6 days agoOn Thursday, Jones Trading adjusted its outlook on Anavex Life Sciences (NASDAQ:AVXL), a...
LIVING WELL: New drug approved to treat Alzheimer’s Disease
FOX 16 Little Rock· 2 days agoThe FDA approved a new drug to treat Alzheimer’s Disease.
Congresswoman and Mom of 2 Speaks Candidly About Her Incurable Brain Disease: 'I'm Too Young for...
People Magazine· 7 days agoJennifer Wexton was gearing up for her third term as a United States congresswoman in late 2022 when...